Advertisement
Advertisement
Catalent, Inc. (CTLT)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:03PM EDT
After hours:
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 99.73 |
| Open | 101.03 |
| Bid | 71.00 x 1000 |
| Ask | 106.21 x 800 |
| Day's Range | 101.88 - 105.41 |
| 52 Week Range | 86.34 - 142.64 |
| Volume | |
| Avg. Volume | 1,253,336 |
| Market Cap | 18.038B |
| Beta (5Y Monthly) | 1.38 |
| PE Ratio (TTM) | 33.17 |
| EPS (TTM) | 3.18 |
| Earnings Date | Jan 31, 2022 - Feb 04, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 138.15 |
- Business Wire
Catalent, Inc. to Present at June Investor Conferences
SOMERSET, N.J., May 27, 2022--Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that members of its executive leadership team will present at two upcoming investor conferences.
- Zacks
Catalent's (CTLT) Latest Facility Expansion to Boost Capacity
Catalent's (CTLT) latest site expansion is expected to significantly boost its business.
- Zacks
Reasons to Retain Catalent (CTLT) Stock in Your Portfolio
Catalent's (CTLT) robust facility expansion activities and a slew of strategic deals raise optimism on the stock.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
